Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

QR Code

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

Michael A Via1, Himani Chandra2, Takako Araki1, Matthew V Potenza3, Maria Skamagas41Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, New York, NY, USA; 2Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, Jam...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Michael A Via, Himani Chandra, Takako Araki, et al
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2010
Sujets:	Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/8db9092bc7954a75aa607adcf098547f
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
par: Via MA
Publié: (2010)

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
par: Powell DR, et autres
Publié: (2015)

Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes
par: Priyanka Gunasekara, et autres
Publié: (2011)

Glycemic control and anti-osteopathic effect of propolis in diabetic rats
par: Al-Hariri M,&nbsp;Gamal Eldin T, et autres
Publié: (2011)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
par: Robert G Moses
Publié: (2010)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
par: Jean-Pierre Le Floch
Publié: (2010)

The role of insulin glulisine to improve glycemic control in children with diabetes mellitus
par: Carter J, et autres
Publié: (2010)

Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control
par: Di Pierro F, et autres
Publié: (2012)

Myocardial perfusion imaging for evaluation of suspected ischemia and its relationship with glycemic control in South African subjects with diabetes mellitus
par: Shmendi A, et autres
Publié: (2014)

Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years
par: MacConell L, et autres
Publié: (2013)

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
par: Kostev K, et autres
Publié: (2015)

Level of sustained glycemic control and associated factors among patients with diabetes mellitus in Ethiopia: a hospital-based cross-sectional study
par: Abebe SM, et autres
Publié: (2015)

Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design
par: Thomas Strack, et autres
Publié: (2009)

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
par: Penfornis A, et autres
Publié: (2015)

Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam &ndash; a clinical perspective
par: Ronald B Goldberg
Publié: (2009)

Leukocyte peroxidase and leptin: an associated link of glycemic tolerance and bronchial asthma?
par: Sergio Parco
Publié: (2010)

Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations
par: Babakr AT, et autres
Publié: (2014)

Poor Glycemic Control and Its Contributing Factors Among Type 2 Diabetes Patients at Adama Hospital Medical College in East Ethiopia
par: Yosef T, et autres
Publié: (2021)

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial
par: Srivanichakorn W, et autres
Publié: (2015)

Lycopene Improves the Metformin Effects on Glycemic Control and Decreases Biomarkers of Glycoxidative Stress in Diabetic Rats
par: Figueiredo ID, et autres
Publié: (2020)

Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia
par: Fasil A, et autres
Publié: (2018)

The Features of Pathobiology and Clinical translation of Approved treatments for Coronavirus Disease 2019 (COVID-19)
par: Ali Fallah, et autres
Publié: (2021)

AMPK activation: a therapeutic target for type 2 diabetes?
par: Coughlan KA, et autres
Publié: (2014)

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
par: Zambad SP, et autres
Publié: (2013)

Standardized Glycemic Management versus Conventional Glycemic Management and Postoperative Outcomes in Type 2 Diabetes Patients Undergoing Elective Surgery
par: Vongsumran N, et autres
Publié: (2020)

Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol® on glycemic control of subjects with impaired fasting glucose
par: Evans M, et autres
Publié: (2015)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
par: Peter J Donovan, et autres
Publié: (2010)

GABAergic system in the endocrine pancreas: a new target for diabetes treatment
par: Wan Y, et autres
Publié: (2015)

Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-&kappa;B suppression
par: Sirada Rungseesantivanon, et autres
Publié: (2010)

Current management strategies to target the increasing incidence of diabetes within Pakistan [Corrigendum]
par: Basit A, et autres
Publié: (2019)

Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
par: Saunders WB, et autres
Publié: (2016)

Glycemic Control, Diabetes Complications and Their Determinants Among Ambulatory Diabetes Mellitus Patients in Southwest Ethiopia: A Prospective Cross-Sectional Study
par: YimamAhmed M, et autres
Publié: (2020)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
par: Moses R
Publié: (2010)

Diabetes and depression in Lebanon and association with glycemic control: a cross-sectional study
par: Ahmadieh H, et autres
Publié: (2018)

Racial Variation in the Relationship of Glycemic Control with Fracture Risk in Elderly Patients with Diabetes
par: Figaro MK, et autres
Publié: (2020)

Optimizing weight control in diabetes: antidiabetic drug selection
par: S Kalra, et autres
Publié: (2010)

The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia
par: Alzaheb RA, et autres
Publié: (2018)

Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
par: B Shariat-Madar, et autres
Publié: (2010)

Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation
par: Lamos EM, et autres
Publié: (2017)

Leukocyte peroxidase and leptin: an associated link of glycemic tolerance and bronchial asthma?
par: Parco S
Publié: (2010)